Home
KRYS
KRYS News

Latest Krystal Biotech Inc. (KRYS) News on January 19, 2025

Argus Research

4 days ago

KRYS: Lowering target price to $150.00

Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer

GlobeNewswire

5 days ago

Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer

3 US Growth Stocks With Insider Ownership Expecting Up To 85% Earnings Growth

Simply Wall St.

a month ago

3 US Growth Stocks With Insider Ownership Expecting Up To 85% Earnings Growth

Argus Research

a month ago

KRYS: Lowering target price to $169.00

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall St.

a month ago

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707

Zacks

a month ago

KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707

MT Newswires

a month ago

Krystal Biotech Says Initial Results From Kyanite-1 Trial Show 'Early Evidence' of Monotherapy Activity

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

GlobeNewswire

a month ago

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

Argus Research

a month ago

KRYS: Lowering target price to $177.00

MT Newswires

a month ago

Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing

KRYS Stock Down on Initial Clinical Updates on KB407 & KB408

Zacks

a month ago

KRYS Stock Down on Initial Clinical Updates on KB407 & KB408

Krystal Biotech announces initial update for KB408, KB407

TipRanks

a month ago

Krystal Biotech announces initial update for KB408, KB407

Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report?

Zacks

a month ago

Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report?

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

GlobeNewswire

a month ago

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

Argus Research

a month ago

KRYS: What does Argus have to say about KRYS?

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

GlobeNewswire

a month ago

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

Zacks

a month ago

Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Zacks

a month ago

Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?

Argus Research

2 months ago

KRYS: Lowering target price to $195.00

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Krystal Biotech to Present at Upcoming Investor Conferences

GlobeNewswire

2 months ago

Krystal Biotech to Present at Upcoming Investor Conferences

Argus Research

2 months ago

KRYS: Raising target price to $206.00

Argus Research

2 months ago

KRYS: Raising target price to $197.00

High Growth Tech Stocks Featuring Three Prominent US Companies

Simply Wall St.

2 months ago

High Growth Tech Stocks Featuring Three Prominent US Companies

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

GlobeNewswire

2 months ago

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

US Exchange Highlights 3 Growth Stocks With Strong Insider Ownership

Simply Wall St.

2 months ago

US Exchange Highlights 3 Growth Stocks With Strong Insider Ownership

Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Simply Wall St.

2 months ago

Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

GlobeNewswire

2 months ago

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

Argus Research

2 months ago

KRYS: Lowering target price to $183.00

Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction

Zacks

2 months ago

Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction

Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Krystal Biotech Inc Earnings Call

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

2 months ago

Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates

Zacks

2 months ago

Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates

MT Newswires

2 months ago

Krystal Biotech's Q3 Net Income Falls, Revenue Rises

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

2 months ago

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results

GuruFocus.com

3 months ago

Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results

Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?

Zacks

3 months ago

Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?

Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know

Zacks

3 months ago

Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Zacks

3 months ago

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

GlobeNewswire

3 months ago

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy

State Street Corp's Strategic Acquisition in Krystal Biotech Inc

GuruFocus.com

3 months ago

State Street Corp's Strategic Acquisition in Krystal Biotech Inc

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in the United States

US Growth Stocks With High Insider Ownership

Simply Wall St.

3 months ago

US Growth Stocks With High Insider Ownership

Argus Research

3 months ago

KRYS: Lowering target price to $184.00

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

Zacks

4 months ago

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

Zacks

4 months ago

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

Zacks

4 months ago

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble?

Insider Monkey

4 months ago

Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble?

Longboard Stock Soars on FDA Designations for Epilepsy Drug

Zacks

4 months ago

Longboard Stock Soars on FDA Designations for Epilepsy Drug

J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC

Zacks

4 months ago

J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Zacks

4 months ago

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Biotech Stock Offers A Buy Point After 256% Average Yearly Gain

Investor's Business Daily

4 months ago

Biotech Stock Offers A Buy Point After 256% Average Yearly Gain

MT Newswires

4 months ago

Krystal Biotech Insider Sold Shares Worth $9,888,276, According to a Recent SEC Filing

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

GlobeNewswire

4 months ago

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?

Zacks

4 months ago

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?

Top US Growth Companies With High Insider Ownership

Simply Wall St.

4 months ago

Top US Growth Companies With High Insider Ownership

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks in the United States

Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

4 months ago

Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock

Zacks

5 months ago

Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock

Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow?

Zacks

5 months ago

Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow?

MT Newswires

5 months ago

Krystal Biotech's Aesthetic Drug Shows Promise in Phase 1 Study for Wrinkle Improvement

Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté

GlobeNewswire

5 months ago

Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté

Argus Research

5 months ago

KRYS: Lowering target price to $208.00

MT Newswires

5 months ago

Evercore ISI Lifts Price Target on Krystal Biotech to $206 From $201, Keeps Outperform Rating

Argus Research

5 months ago

KRYS: Raising target price to $209.00

Krystal Biotech's (NASDAQ:KRYS) Earnings Might Be Weaker Than You Think

Simply Wall St.

5 months ago

Krystal Biotech's (NASDAQ:KRYS) Earnings Might Be Weaker Than You Think

Top US Growth Stocks With High Insider Ownership

Simply Wall St.

5 months ago

Top US Growth Stocks With High Insider Ownership

Best Momentum Stock to Buy for August 8th

Zacks

5 months ago

Best Momentum Stock to Buy for August 8th

Krystal Biotech, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St.

5 months ago

Krystal Biotech, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krystal Biotech (KRYS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

5 months ago

Krystal Biotech (KRYS) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

5 months ago

Citigroup Downgrades Krystal Biotech to Neutral From Buy, Adjusts Price Target to $204 From $195

MT Newswires

5 months ago

Chardan Research Adjusts Price Target on Krystal Biotech to $208 From $153, Maintains Buy Rating

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Krystal Biotech Inc Earnings Call

Associated Press Finance

5 months ago

Apple, Krystal Biotech fall; Tyson Foods, Kellanova rise, Monday, 8/5/2024

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Top Estimates

Zacks

5 months ago

Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Top Estimates

MT Newswires

5 months ago

Krystal Biotech's Q2 Swings to Profit

Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

5 months ago

Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates

After A 65% Run This Year, Krystal Biotech Has Plenty More In The Tank

Investor's Business Daily

6 months ago

After A 65% Run This Year, Krystal Biotech Has Plenty More In The Tank

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

Zacks

6 months ago

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024

GlobeNewswire

6 months ago

Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024

Argus Research

6 months ago

KRYS: Lowering target price to $218.00

Krystal Biotech (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

6 months ago

Krystal Biotech (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why

Argus Research

6 months ago

KRYS: Raising target price to $219.00

Unveiling Three US Growth Companies With High Insider Ownership

Simply Wall St.

6 months ago

Unveiling Three US Growth Companies With High Insider Ownership

Argus Research

6 months ago

KRYS: Raising target price to $203.00

Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin

Insider Monkey

7 months ago

Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin

3 US Growth Companies With High Insider Ownership And Up To 96% Earnings Growth

Simply Wall St.

7 months ago

3 US Growth Companies With High Insider Ownership And Up To 96% Earnings Growth

MT Newswires

7 months ago

Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing

Krystal Biotech Stock Sees RS Rating Jump To 91

Investor's Business Daily

7 months ago

Krystal Biotech Stock Sees RS Rating Jump To 91

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire

7 months ago

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

"Green Energy" Brings Charging Piles to Mountain Villages

PR Newswire

7 months ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GlobeNewswire

7 months ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

Exploring James Halstead And Two More Top Dividend Stocks In The UK

Simply Wall St.

7 months ago

Exploring James Halstead And Two More Top Dividend Stocks In The UK

If You'd Invested $1,000 in Nvidia Stock 5 Years Ago, Here's How Much You'd Have Today

Motley Fool

7 months ago

If You'd Invested $1,000 in Nvidia Stock 5 Years Ago, Here's How Much You'd Have Today

Omega Pacific Receives OTCQB Approval

ACCESSWIRE

7 months ago

Omega Pacific Receives OTCQB Approval

Global Cloud ITSM Market Forecast Report 2024-2029, with Case Studies of Algar Tech, Grupo Moura, Deutsche Telekom, Opentext and Freshworks

GlobeNewswire

7 months ago

Global Cloud ITSM Market Forecast Report 2024-2029, with Case Studies of Algar Tech, Grupo Moura, Deutsche Telekom, Opentext and Freshworks

Stock market today: Asian stocks are mixed ahead of key U.S. jobs data

Associated Press Finance

7 months ago

Stock market today: Asian stocks are mixed ahead of key U.S. jobs data

Insider Sale: Director Mark Beck Sells Shares of Owens & Minor Inc (OMI)

GuruFocus.com

7 months ago

Insider Sale: Director Mark Beck Sells Shares of Owens & Minor Inc (OMI)

Share on Social Networks: